Biochem/physiol Actions
ED50 = 2.5-12.5 ng/ml as measured in a serum-free proliferation assay using MCF7 human breast adenocarcinoma cells.
General description
Recombinant, human neuregulin 1-β1/heregulin 1-β1 extracellular domain (NRG1-beta1/HRG1-beta1 ECD) consisting of amino acids 2-246 and expressed in E. coli. All NRG1 isoforms contain an EGF-like domain (β-splice variant) that is used to directly bind to the ErbB3 or ErbB4 receptor tyrosine kinases.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Buonanno, A., and G.D Fischbach 2001. Curr. Opin. Neurobiol.11, 287.Adlkofer, K. and C. Lai 2000. Glia29, 104.Garratt, A.N. et al., 2000. BioEssays22, 987.Karey, K.P., et al. 1988. Cancer Res.48, 4083.
Packaging
50 µg in Glass bottle
Physical form
Lyophilized from 0.2 µm filtered acetonitrile, TFA, BSA.
Reconstitution
Reconstitute 50 100 µg/ml with sterile PBS containing ≥1% human or bovine serum albumin.
Following reconstitution refrigerate (4°C) for short term-storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria: